KT Signs MOU with Acryl to Expand Medical AI Services

KT is collaborating with medical artificial intelligence (AI) company Acryl to jointly advance medical AI transformation (AX) initiatives.

On October 20, KT's Executive Vice President Noh Hyung-rae and Acryl CEO Park Oe-jin attended the signing of a memorandum of understanding.

The partnership aims to combine KT's capabilities in AI, cloud, and data integration with Acryl's expertise in medical data and AI technology, as well as its experience in hospital implementation and validation, to jointly develop customized AX business models for healthcare institutions.

KT and Acryl plan to address the increasing demand for data utilization and AI services in medical settings by promoting the standardization and utilization of medical data, jointly discovering and validating medical AI technologies and services, and advancing research and commercialization of medical AI.

The two companies will work together on joint proposals and validations for healthcare institutions, establishing a collaborative framework that spans from technology verification to actual commercialization. They also intend to explore government and public research projects and new business opportunities.

Additionally, KT unveiled a 'medical standardization model' that encompasses infrastructure tailored to hospital needs, data platforms, and AI services. The company is supporting the adoption of AX in general hospitals and plans to expand its application areas through partnerships with medical professionals.

Noh Hyung-rae, Executive Vice President of KT's Enterprise Division, stated, "The key to medical AX is connecting the data held by hospitals to actual clinical practice, research, and operations to create tangible changes in the field. Through this collaboration with Acryl, we aim to strengthen the foundation for applying medical AX services on-site and promote customized projects linked to KT's medical standardization model to drive the expansion of medical AX."